Oli 968 – New drug formulation targets hunger hormones in bariatric treatment.

Dr Shanker Pasupathy from HMI Medical Centre shared insights on a new drug formulation used in bariatric treatment that targets hunger hormones to help suppress appetite. By reducing feelings of hunger, the treatment can support obese patients in achieving sustainable weight loss and improving the overall success of their weight management journey.